MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Bard nabs angioplasty balloon maker for $325 million | Acquisitions Roundup

Bard nabs angioplasty balloon maker for $325 million | Acquisitions Roundup

By

C.R. Bard logo
Lutonix logo

C.R. Bard (NYSE:BCR) acquired Minneapolis-based angioplasty balloon maker Lutonix Inc. for $325 million.

The merger, announced during Bard’s 2012 guidance update conference call, grants Lutonix $225 million up front with another $100 million when Lutonix achieves pre-market approval for its drug-coated balloons.

Lutonix is conducting the first and only investigational device exemption trial approved by the FDA for a drug-coated percutaneous transluminal angioplasty balloon for treatment of peripheral artery disease, according to a press release.

"Lutonix has the only third-generation drug-coated balloon technology. They also have a significant lead with respect to U.S. launch, outstanding quality and depth of pre-clinical science, a strong clinical program, a very skilled and motivated team, and a coating technology we believe will demonstrate superior safety and efficacy," Bard chairman & CEO Timothy Ring said in prepared remarks. "This position of leadership in a large potential market, combined with our current market leadership in PTA, makes this acquisition a compelling strategic fit for Bard."

Lutonix enrolled the first patient in its Levant 2 clinical trial, the largest randomized peripheral drug-coated balloon trial to date, in July 2011. PMA submission could occur in 2014, the company estimates.

The devices have CE Mark approval for sale in Europe, and Bard plans to begin sales in the European Union during the second half of 2012, concurrent with larger registry studies to support broader marketing claims.

No such devices are cleared for the U.S. just yet.

Bard expects the merger to reduce 2012 earnings per share by about 25 cents, according to a press release.

The merger hasn’t done much for BCR stock, which dove more than 5 percent to $83.20 by about 10:45 a.m. today after closing at $87.78 last night.

Here’s a roundup of companies announcing mergers, acquisitions and divestitures.

Mergers and Acquisitions

Mindray Medical to grab controlling share in Chinese diagnostic company
Mindray Medical International (NYSE:MR) agreed to acquire a controlling stake in Chinese diagnostics company Hunan Changsha Tiandiren Biotech Co. Ltd. The terms of the deal were not made public. Read more

iMedX acquires Abacus

iMedX nabbed up more of its competition in the electronic medical record management systems by acquiring the assets of Abacus Transcriptions Inc. for an undisclosed amount.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Mass General researchers tout low-cost, portable brain imaging scanner
    Researchers at Massachusetts General Hospital are touting a low-cost, portable “head only” MRI scanner that could be used in multiple settings. As opposed to standard costly, immobile MRI scanners that require special infrastructure, the MGH researchers developed a low-cost, compact, portable and low-power scanner that could be mounted in an ambulance, wheeled into a patient’s… […]
  • HHS confirms involvement in presidential transition process
    U.S. Health and Human Services Dept. Secretary Alex Azar confirmed that HHS is working with president-elect Joe Biden on a presidential transition. Speaking during a press briefing, Azar said HHS is in contact with the transition team after the General Services Administration formally recognized Biden as the president-elect, having previously sidestepped questions regarding the potential… […]
  • Swiss scientists make ‘micromachines’ for self-deploying stents and more
    Researchers in Zurich reported today that they have invented a manufacturing technique to build “micromachines” out of metal and plastic in which these two materials are interlocked as closely as links in a chain. These robots are so tiny that they can maneuver through blood vessels and deliver medications to certain points in the body… […]
  • This AI algorithm could detect COVID-19 in chest X-rays
    Northwestern University researchers are touting a new AI platform that can detect COVID-19 in X-ray images of the lungs. DeepCOVID-XR, a machine-learning algorithm, performed better than a team of specialized thoracic radiologists by spotting COVID-19 in X-rays about 10 times faster and 1%-6% more accurately, according to a news release. Researchers involved think physicians could… […]
  • Aspen Surgical acquires Protek Medical Products
    Disposable products maker Aspen Surgical Products today announced the acquisition of Protek Medical Products (Coralville, Iowa). Protek manufactures single-use ultrasonic probe covers and needle guides used in tissue biopsies, fluid aspiration, and vascular access procedures as well as protective covers for medical instruments and equipment. The acquisition of Protek strengthens Aspen’s portfolio of medical, patient… […]
  • Puritan Medical lands $11.6M to boost swab production
    Puritan Medical Products (Guilford, Maine) has been awarded $11.6 million to expand its COVID-19 testing swab production by 3 million swabs per month, according to U.S. Sen. Susan Collins (R-Maine). The award was funded through the Paycheck Protection Program and Health Care Enhancement Act enacted in April. It will help fund modifications to Puritan’s newest… […]
  • PTI Engineered Plastics wins ‘best workplace’ award
    PTI Engineered Plastics has been awarded a Top Workplaces 2020 honor by The Detroit Free Press. The list is based solely on employee feedback gathered through a third-party survey administered by research partner Energage, according to the Macomb, Mich.-based company. An anonymous employee survey measured 15 drivers of engaged workplace cultures, including alignment, execution, and… […]
  • SyBridge enters medtech market with acquisition of X-Cell Tool & Mold
    SyBridge Technologies announced that it has completed the acquisition of X-Cell Tool & Mold, marking its first acquisition in the medical tooling industry. Fairview, Pa.-based X-Cell manufactures close-tolerance and multi-cavity plastic injection molds primarily for the medical industry. Its acquisition expands SyBridge’s tooling capabilities to include highly complex precision tooling solutions necessary for medical devices.… […]
  • Why making a lot of ventilators may not be enough to prevent COVID-19 deaths
    Medical device companies and even manufacturers outside the industry answered the call to make ventilators needed to treat people with severe COVID-19 cases. But as a newer and larger wave of the novel coronavirus hits the U.S., the equipment may not be enough, The New York Times reported yesterday. The problem, according to the Times,… […]
  • Demand, flexible financing fuel strong Mako sales for Stryker
    Stryker’s (NYSE:SYK) Mako surgical system remains a strong seller, even as hospitals grapple with pandemic-induced cuts to revenue. The orthopedics giant announced the placement of its 1,000th system in September. Those results stem not only from demand but also from financing options Stryker has extended to some hospitals, according to Spencer Stiles, group president of the… […]
  • MedTech Europe gives proposed European Health Union a partial nod
    MedTech Europe has endorsed a new plan to strengthen the EU’s response to future pandemics and public health emergencies, with a few caveats. European Commission President Ursula von der Leyen outlined the plan to create a European Health Union in her state of the union speech on Nov. 11. The plan is a response to… […]

Leave a Reply